XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Note 6 - Stockholders' Equity, Stock Options and Warrants
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Equity [Text Block]

NOTE 6 STOCKHOLDERS EQUITY, STOCK OPTIONS AND WARRANTS

 

Series F Preferred Stock Dividend and Reverse Stock Split

 

On March 16, 2023, the Board of Directors of the Company authorized the issuance of 80,000 shares of Series F Preferred Stock, par value $0.01 per share.

 

On March 16, 2023, the Board of Directors of the Company declared a dividend of one one-thousandth of a share of Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held on record as of March 27, 2023. 79,404 shares of Series F Preferred Stock were issued pursuant to the stock dividend. Each share of Series F Preferred Stock entitled the holder thereof to 1,000,000 votes per share to vote together with the outstanding shares of common stock of the Company as a single class to adopt an amendment to the Company’s Certificate of Incorporation to affect a reverse stock split.

 

On April 19, 2023, the Company completed a one-for-twenty reverse stock split that was effective for trading purposes on April 24, 2023. No fractional shares were issued as a result of the reverse stock split. Any fractional shares that would otherwise have resulted from the reverse stock split were rounded up to the next whole number. The number of authorized shares of common stock under the Company’s certificate of incorporation, as amended, remained unchanged at 200,000,000 shares. All numbers of shares and per-share amounts in this report have been adjusted to reflect the reverse split. Proportionate reductions were made to the number of shares of common stock reserved for future issuance under our 2012 Equity Incentive Plan and the number of shares of common stock that may be issued upon exercise or vesting of outstanding equity incentive awards and warrants, and proportionate increases were made to the exercise price or share-based performance criteria, if any, applicable to such awards and warrants.

 

Redemption of Series F Preferred Stock

 

On April 17, 2023, the Company convened a special meeting of stockholders, which was adjourned due to the lack of a quorum and reconvened on April 19, 2023 (the “Special Meeting”), at which the Company’s stockholders approved a proposal to amend the Company’s certificate of incorporation to effect a reverse stock split of the Company’s common stock at a ratio in the range of 1-for-2 to 1-for-25, with such ratio to be determined by the Company’s Board of Directors (the “Reverse Split Proposal”). All shares of Series F Preferred Stock that were not present in person or by proxy at the Special Meeting as of immediately prior to the opening of the polls (the “Initial Redemption Time”) were automatically redeemed (the “Initial Redemption”). All outstanding shares of Series F Preferred Stock that were not redeemed pursuant to the Initial Redemption were redeemed automatically upon the approval by the Company’s stockholders of the Reverse Split Proposal (the “Subsequent Redemption” and, together with the Initial Redemption, the “Redemption”). Both the Initial Redemption and the Subsequent Redemption occurred on April 19, 2023. As a result, no shares of Series F Preferred Stock remain outstanding.

 

Equity Incentive Plan

 

The Company has an equity incentive plan, which allows issuance of incentive and non-qualified stock options to employees, directors, and consultants of the Company, where permitted under the plan. The exercise price for each stock option is determined by the Board of Directors. Vesting requirements are determined by the Board of Directors when granted and currently range from immediate to three years. Options under this plan have terms ranging from three to ten years.

 

The following summarizes transactions for stock options and warrants for the periods indicated:

 

  

Stock Options

  

Warrants

 
  

Number of
Shares

  

Average
Exercise
Price

  

Number of
Shares

  

Average
Exercise
Price

 

Outstanding at December 31, 2021

  53,144  $96.60   1,584,995  $33.20 
                 

Issued

  1,599   8.40   1,053,136   14.00 

Forfeited

  (2,013

)

  17.60   -   - 

Expired

  (3,677

)

  208.40   (5,422

)

  329.60 

Cancelled

  -   -   (816,272

)

  30.20 

Outstanding at December 31, 2022

  49,053  $91.69   1,816,437  $22.60 
                 

Issued

  868   5.61   -   - 

Forfeited

  (35

)

  2.84   -   - 

Expired

  (1,849

)

  108.05   (4,058

)

  200.00 

Outstanding at June 30, 2023

  48,037  $84.42   1,812,379  $22.20 

 

Stock-based compensation expense recognized for the three months ended June 30, 2023 and June 30, 2022 was $5,872 and $39,383, respectively. Stock-based compensation expense recognized for the six months ended June 30, 2023 and June 30, 2022 was $15,159 and $75,901, respectively. The Company has $3,964 of unrecognized compensation expense related to non-vested stock options that is expected to be recognized over the next 21 months and $11,818 of unrecognized compensation expense related to non-vested restricted stock units that is expected to be recognized over the next 7 months. At June 30, 2023, there were 2,500 restricted stock units (“RSUs”) outstanding under the plan.